Age and sex influences on urine calcitonin-like immunoreactivity in normal subjects. 1986

S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara

Calcitonin-like immunoreactivity levels were determined in urine specimens in 585 normal subjects of various ages. Urine calcitonin-like immunoreactivity (uCTi) was measured by the midportion-specific radioimmunoassay after extraction of urine by gel chromatography on a 0.8 X 20 cm column of Bio Gel P-2. In 197 males and 169 females below 20 years old, significant negative correlations between the age and uCTi were observed (male: r = -0.684, female: r = -0.690). In 75 males and 80 females above 41 years, however, no significant correlation was observed between age and uCTi. The high level of uCTi in children could be explained by high levels of circulating calcitonin, associated with rapid bone growth; however the uCTi level in the elderly may not reflect the physiological significance of calcitonin for them because of a suspected age-related decrease in renal clearance of uCTi in the elderly.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
January 1984, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
March 1988, Clinical chemistry,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
April 1987, Rinsho byori. The Japanese journal of clinical pathology,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
July 1981, Pediatric research,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
October 1990, The Journal of clinical endocrinology and metabolism,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
October 1986, Clinica chimica acta; international journal of clinical chemistry,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
May 1965, Metabolism: clinical and experimental,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
February 1990, Regulatory peptides,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
January 1980, Scandinavian journal of gastroenterology. Supplement,
S Morimoto, and K Fukuo, and H Yamamoto, and S Imanaka, and E Koh, and T Hironaka, and T Shiraishi, and T Onishi, and L V Avioli, and Y Kumahara
January 1955, Archivio di patologia e clinica medica,
Copied contents to your clipboard!